TY - JOUR
T1 - Refining the Primrose syndrome phenotype
T2 - A study of five patients with ZBTB20 de novo variants and a review of the literature
AU - Cleaver, Ruth
AU - Berg, Jonathan
AU - Craft, Emily
AU - Foster, Alison
AU - Gibbons, Richard J.
AU - Hobson, Emma
AU - Lachlan, Katherine
AU - Naik, Swati
AU - Sampson, Julian R.
AU - Sharif, Saba
AU - Smithson, Sarah
AU - Deciphering Developmental Disorders (DDD) Study
AU - Parker, Michael J.
AU - Tatton-Brown, Katrina
N1 - © 2019 Wiley Periodicals, Inc.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Primrose syndrome is a rare autosomal dominant condition caused by heterozygous missense variants within ZBTB20. Through an exome sequencing approach (as part of the Deciphering Developmental Disorders [DDD] study) we have identified five unrelated individuals with previously unreported, de novo ZBTB20 pathogenic missense variants. All five missense variants targeted the C2H2 zinc finger domains. This genotype-up approach has allowed further refinement of the Primrose syndrome phenotype. Major characteristics (>90% individuals) include an intellectual disability (most frequently in the moderate range), a recognizable facial appearance and brain MRI abnormalities, particularly abnormalities of the corpus callosum. Other frequent clinical associations (in 50–90% individuals) include sensorineural hearing loss (83%), hypotonia (78%), cryptorchidism in males (75%), macrocephaly (72%), behavioral issues (56%), and dysplastic/hypoplastic nails (57%). Based upon these clinical data we discuss our current management of patients with Primrose syndrome.
AB - Primrose syndrome is a rare autosomal dominant condition caused by heterozygous missense variants within ZBTB20. Through an exome sequencing approach (as part of the Deciphering Developmental Disorders [DDD] study) we have identified five unrelated individuals with previously unreported, de novo ZBTB20 pathogenic missense variants. All five missense variants targeted the C2H2 zinc finger domains. This genotype-up approach has allowed further refinement of the Primrose syndrome phenotype. Major characteristics (>90% individuals) include an intellectual disability (most frequently in the moderate range), a recognizable facial appearance and brain MRI abnormalities, particularly abnormalities of the corpus callosum. Other frequent clinical associations (in 50–90% individuals) include sensorineural hearing loss (83%), hypotonia (78%), cryptorchidism in males (75%), macrocephaly (72%), behavioral issues (56%), and dysplastic/hypoplastic nails (57%). Based upon these clinical data we discuss our current management of patients with Primrose syndrome.
KW - DDD study
KW - exome sequencing
KW - intellectual disability
KW - Primrose syndrome
KW - ZBTB20
UR - http://www.scopus.com/inward/record.url?scp=85059940246&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.61024
DO - 10.1002/ajmg.a.61024
M3 - Article
C2 - 30637921
AN - SCOPUS:85059940246
SN - 1552-4825
VL - 179
SP - 344
EP - 349
JO - American Journal of Medical Genetics Part A
JF - American Journal of Medical Genetics Part A
IS - 3
ER -